Evidence map›Paper›PMID 31700639›Full record

ArticleUnited European gastroenterology journal2019

Validation of a score chart to predict the risk of chronic mesenteric ischemia and development of an updated score chart.

Louisa Jd van Dijk, Desirée van Noord, Robert H Geelkerken, Jihan Harki, Sophie A Berendsen, Annemarie C de Vries, Adriaan Moelker, Yvonne Vergouwe, Hence Jm Verhagen, Jeroen J Kolkman and 2 more

Open access · hybridAbstract readValidation Study
In one paragraph

Article in United European gastroenterology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Louisa Jd van DijkDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-6507-5666
Desirée van NoordDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Robert H GeelkerkenDepartment of Surgery, Medisch Spectrum Twente and Multimodality Medical Imaging group, TechMed Centre, Faculty Science and Technology, University Twente, Enschede, the Netherlands.ORCID 0000-0003-4640-8725
Jihan HarkiDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Sophie A BerendsenDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Annemarie C de VriesDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Adriaan MoelkerDepartment of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Yvonne VergouweDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Hence Jm VerhagenDepartment of Vascular Surgery, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Jeroen J KolkmanDepartment of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, the Netherlands.
Marco J BrunoDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Dutch Mesenteric Ischemia Study group
Erasmus MC · NLMedisch Spectrum Twente · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: The objective of this article is to externally validate and update a recently published score chart for chronic mesenteric ischemia (CMI). Methods: A multicenter prospective cohort analysis was conducted of 666 CMI-suspected patients referred to two Dutch specialized CMI centers. Multidisciplinary consultation resulted in expert-based consensus diagnosis after which CMI consensus patients were treated. A definitive diagnosis of CMI was established if successful treatment resulted in durable symptom relief. The absolute CMI risk was calculated and discriminative ability of the original chart was assessed by the Results: In 8% of low-risk patients, 39% of intermediate-risk patients and 94% of high-risk patients of the validation cohort, CMI was diagnosed. Discriminative ability of the original model was acceptable ( Conclusion: The CMI prediction model performs and discriminates well in the validation cohort. The updated score chart has excellent discriminative ability and is useful in clinical decision making.

Indexed as

AdultAgedAged, 80 and overAngiographyCardiovascular DiseasesCeliac ArteryChronic DiseaseCohort StudiesConstriction, PathologicFemaleHumansMaleMedian Arcuate Ligament SyndromeMesenteric ArteriesMesenteric Artery, SuperiorMesenteric IschemiaVasodilator AgentsAngiographyatherosclerosisceliac arterychronic mesenteric ischemiacomputed tomography magnetic resonance angiographymedian arcuate ligament syndromeprediction modelsuperior mesenteric artery

Identifiers

PMID31700639
PMCPMC6826523
OpenAlexW2950233249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.